Determinants of Loss to Follow-Up Among MDR-TB Patients
| Autor: | Rizky Maharja, Riadnin Maharja, Nur Nasry Noor, Apik Indarti Moedjiono, Wahiduddin, Hasanuddin Ishak, Andi Zulkifli |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Tuberculosis Social stigma business.industry Health Toxicology and Mutagenesis Family support Isoniazid Case-control study Odds ratio Toxicology medicine.disease Pathology and Forensic Medicine Internal medicine medicine Drug side effects business Law Rifampicin medicine.drug |
| Zdroj: | Indian Journal of Forensic Medicine & Toxicology. |
| ISSN: | 0973-9130 0973-9122 |
| Popis: | Cases of tuberculosis has gotten worse since results of global surveillance revealed that mycobacterium isresistant to rifampicin and isoniazid. It can cause Loss to Follow-Up among MDR-TB patients. The purposeof this study is Determinants of Loss to Follow-Up among MDR-TB Patients. This research is an analyticobservational study with a case control study design with a retrospective approach. Cases were MDR-TBpatients who dropped out of treatment as much 27 people, while controls were subjects with MDR-TBpatients who did not Loss to Follow-Up of treatment as much 83 people. Data analysis was performedby looking at the Odds Ratio value. The result showed that knowledge (OR = 5.28, 95% CI = 1.410347–29.19908), drug side effect (OR = 32.324332, 95% CI = 4.732715–1353.07), family support (OR = 5.01875,95% CI = 1.602489 – 15.57846), social stigma (OR = 6.712963, 95% CI = 1.473798–61.68985) were thedeterminants of loss to follow up among MDR-TB patients. It can conclude that determinants of loss tofollow-up among MDR-TB patients include knowledge, drug side effects, family support, and social stigma. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|